Literature DB >> 10926703

Epidemiology of bacteriuria caused by vancomycin-resistant enterococci--a retrospective study.

A H Wong1, R P Wenzel, M B Edmond.   

Abstract

BACKGROUND: The epidemiology of vancomycin-resistant enterococcal (VRE) bacteriuria has not been previously described. Our objectives are to describe the frequency of VRE bacteriuria, to use strict definitions to distinguish symptomatic urinary tract infection (UTI) versus urine colonization without pyuria versus asymptomatic bacteriuria with pyuria, and to describe the outcomes of each group.
METHODS: We used a retrospective analysis of patients with VRE bacteriuria in an academic medical center.
RESULTS: During the 18-month study period, 98 of the 107 patients (92%) with urine cultures positive for VRE (23/10,000 admissions), had charts that were available for review. In 94 of 98 patients, the organism was Enterococcus faecium, and in only 4 was Enterococcus faecalis recovered. Thirty-seven patients were colonized with VRE; 21 patients had asymptomatic bacteriuria, and the status of 27 patients was not ascertainable. Thirteen patients had VRE UTIs with two associated bacteremias and one death. Patients with UTI versus patients without UTI were more likely to have an underlying malignancy (39% vs 9%, P =.014).
CONCLUSION: The majority of urine cultures yielding VRE do not represent true infection, rather colonization or asymptomatic bacteriuria.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10926703     DOI: 10.1067/mic.2000.106904

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  8 in total

1.  Cationic hydrophobic peptides with antimicrobial activity.

Authors:  Margareta Stark; Li-Ping Liu; Charles M Deber
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

2.  Vancomycin resistance has no influence on outcomes of enterococcal bacteriuria.

Authors:  H N Khair; P VanTassell; J P Henderson; D K Warren; J Marschall
Journal:  J Hosp Infect       Date:  2013-08-30       Impact factor: 3.926

3.  Atomic force microscopy study of the effect of antimicrobial peptides on the cell envelope of Escherichia coli.

Authors:  M Meincken; D L Holroyd; M Rautenbach
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  Community-acquired enterococcal urinary tract infections.

Authors:  Maria Bitsori; Sofia Maraki; Maria Raissaki; Anna Bakantaki; Emmanouil Galanakis
Journal:  Pediatr Nephrol       Date:  2005-06-22       Impact factor: 3.714

5.  Clinical significance of bacteriuria with low colony counts of Enterococcus species.

Authors:  R Colodner; T Eliasberg; B Chazan; R Raz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 3.267

6.  Treatment of resistant enterococcal urinary tract infections.

Authors:  Subramanian Swaminathan; George J Alangaden
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

7.  Linezolid to treat urinary tract infections caused by vancomycin-resistant Enterococcus.

Authors:  Benjamin Alan Pontefract; Suzette Amy Rovelsky; Karl Joseph Madaras-Kelly
Journal:  SAGE Open Med       Date:  2020-11-04

8.  Does oral doxycycline treatment affect eradication of urine vancomycin-resistant Enterococcus? A tertiary hospital study.

Authors:  Yoonjung Kim; Sohyun Bae; Soyoon Hwang; Ki Tae Kwon; Hyun-Ha Chang; Su-Jeong Kim; Han-Ki Park; Jong-Myung Lee; Shin-Woo Kim
Journal:  Yeungnam Univ J Med       Date:  2020-02-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.